Hester Biosciences Limited (HESTERBIO) - Total Assets

Latest as of September 2025: Rs6.75 Billion INR ≈ $73.02 Million USD

Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) holds total assets worth Rs6.75 Billion INR (≈ $73.02 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check HESTERBIO cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Hester Biosciences Limited - Total Assets Trend (2006–2025)

This chart illustrates how Hester Biosciences Limited's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Hester Biosciences Limited to see how much of total assets are deployed in long-term investments.

Hester Biosciences Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Hester Biosciences Limited's total assets of Rs6.75 Billion consist of 29.9% current assets and 70.1% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	0.9%
Accounts Receivable	Rs731.81 Million	11.2%
Inventory	Rs703.77 Million	10.8%
Property, Plant & Equipment	Rs4.09 Billion	62.7%
Intangible Assets	Rs66.57 Million	1.0%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Hester Biosciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Hester Biosciences Limited worth.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Hester Biosciences Limited's current assets represent 29.9% of total assets in 2025, a decrease from 68.6% in 2006.
Cash Position: Cash and equivalents constituted 0.9% of total assets in 2025, up from 0.8% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is property, plant & equipment at 62.7% of total assets.

Hester Biosciences Limited Competitors by Total Assets

Key competitors of Hester Biosciences Limited based on total assets are shown below.

Company	Country	Total Assets
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
SIMCERE PHARMAC. GRP LTD F:S2P	Germany	€14.73 Billion
Curaleaf Holdings Inc. TO:CURA	Canada	CA$2.88 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Walvax BioTech SHE:300142	China	CN¥11.13 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion

Hester Biosciences Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.44	1.75	2.22
Quick Ratio	0.98	1.22	1.44
Cash Ratio	0.06	0.13	0.00
Working Capital	Rs623.35 Million	Rs953.77 Million	Rs963.23 Million

Hester Biosciences Limited - Advanced Valuation Insights

This section examines the relationship between Hester Biosciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.94
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	-1.4%
Total Assets	Rs6.53 Billion
Market Capitalization	$189.40 Million USD

Valuation Analysis

Below Book Valuation: The market values Hester Biosciences Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Hester Biosciences Limited's assets decreased by 1.4% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Hester Biosciences Limited (2006–2025)

The table below shows the annual total assets of Hester Biosciences Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs6.53 Billion ≈ $70.66 Million	-1.35%
2024-03-31	Rs6.62 Billion ≈ $71.63 Million	+21.35%
2023-03-31	Rs5.46 Billion ≈ $59.03 Million	-2.91%
2022-03-31	Rs5.62 Billion ≈ $60.80 Million	+36.76%
2021-03-31	Rs4.11 Billion ≈ $44.45 Million	+6.91%
2020-03-31	Rs3.84 Billion ≈ $41.58 Million	+28.39%
2019-03-31	Rs2.99 Billion ≈ $32.38 Million	+22.70%
2018-03-31	Rs2.44 Billion ≈ $26.39 Million	+11.88%
2017-03-31	Rs2.18 Billion ≈ $23.59 Million	+18.37%
2016-03-31	Rs1.84 Billion ≈ $19.93 Million	+15.37%
2015-03-31	Rs1.60 Billion ≈ $17.27 Million	+12.31%
2014-03-31	Rs1.42 Billion ≈ $15.38 Million	+14.97%
2013-03-31	Rs1.24 Billion ≈ $13.38 Million	+29.63%
2012-03-31	Rs954.26 Million ≈ $10.32 Million	+7.11%
2011-03-31	Rs890.87 Million ≈ $9.63 Million	+10.00%
2010-03-31	Rs809.90 Million ≈ $8.76 Million	+8.68%
2009-03-31	Rs745.20 Million ≈ $8.06 Million	+8.56%
2008-03-31	Rs686.42 Million ≈ $7.42 Million	+7.52%
2007-03-31	Rs638.39 Million ≈ $6.90 Million	+184.17%
2006-03-31	Rs224.65 Million ≈ $2.43 Million	--

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic

Market Cap

$189.40 Million

Rs17.51 Billion INR

Market Cap Rank

#16861 Global

#879 in India

Share Price

Rs2058.70

Change (1 day)

+0.30%

52-Week Range

Rs1259.10 - Rs2193.80

All Time High

Rs3204.96